Document is current
Any future updates will be listed below
-
Authors
Silverberg, Jonathan I.
Anderson, Peter
Cappelleri, Joseph C.
Piercy, James
Levenberg, Mark E.
Myers, Daniela E.
Gerber, Robert A.
-
Funding
Funding for this research was provided by:
Pfizer Inc.
- License Information
-
More Information
Article History
Received: 3 December 2024
Revised: 17 January 2025
Accepted: 27 January 2025
First Online: 12 March 2025
Declarations
:
: This study adhered to the ICC/ESOMAR International Code on Market, Opinion and Social Research and Analytics (). Ethical approval was not attained because this was a real-world non-interventional study. Instructions described the survey’s purpose, why respondents were selected, and who might have access to the aggregated and anonymized datasets.
: Before patients could volunteer to complete a questionnaire, they were asked to provide informed consent. Using a checkbox, patients provided informed consent to take part in the survey. Data were collected in such a way that patients and physicians could not be identified directly.
: Not required.
: Jonathan Silverberg has received honoraria or consultant fees for Pfizer Inc., AbbVie, Aldena Therapeutics, Amgen, AOBiome LLC, Arcutis Inc, Arena Pharmaceuticals, Asana Biosciences LLC, ASLAN Pharmaceuticals, BiomX Inc, Biosion, Bodewell, Boehringer Ingelheim, Cara Therapeutics, Castle Biosciences, Celegene, Connect Biopharma LLC, Corrona Inc, Dermavant Sciences, Eli Lilly and Company, Galderma Research & Development LLC, GlaxoSmithKline, Incyte Corporation, LEO Pharma Inc, Optum, Novartis, RAPT Therapeutics, Regeneron, Sanofi, Shaperon, TARGET Pharma, and Union Therapeutics; has served as a speaker for Pfizer Inc., AbbVie, Eli Lilly and Company, Incyte Corporation, LEO Pharma, Maui Derm, Regeneron, and Sanofi Genzyme; and served as an investigator for AbbVie, Eli Lilly and Company, GlaxoSmithKline, Kiniksa Pharmaceutics Ltd, Optum, Regeneron, and TARGET Pharma. Peter Anderson, and James Piercy are employees of Adelphi Real World, a company that received research funding from Pfizer Inc. Daniela E. Myers, Mark E. Levenberg, and Joseph C. Cappelleri are employees and stockholders of Pfizer Inc., which supported this study. Robert A. Gerber was an employee and stockholder of Pfizer Inc at the time this research was conducted.
